...
首页> 外文期刊>Journal of Clinical Immunology >Novel Patient with Late-Onset Familial Hemophagocytic Lymphohistiocytosis with STXBP2 Mutations Presenting with Autoimmune Hepatitis, Neurological Manifestations and Infections Associated with Hypogammaglobulinemia
【24h】

Novel Patient with Late-Onset Familial Hemophagocytic Lymphohistiocytosis with STXBP2 Mutations Presenting with Autoimmune Hepatitis, Neurological Manifestations and Infections Associated with Hypogammaglobulinemia

机译:新型患者,伴有自体免疫性肝炎,神经系统表现和与低血球蛋白血症相关的感染的STXBP2突变的迟发性家族性噬血细胞性淋巴细胞增多症

获取原文
获取原文并翻译 | 示例
           

摘要

Familial hemophagocytic lymphohistiocytosis (FHL) is a genetically heterogeneous hyperinflammatory syndrome, caused by an uncontrolled and ineffective proliferation and activation of T-lymphocytes, NK-cells, and macrophages that infiltrate multiple organs. Herein, a patient is presented who suffered from hepatitis and atypical brain lesions. Genetic studies revealed a homozygous mutation in the STXP2 gene; and thus, the diagnosis of FHL5 was confirmed.
机译:家族性吞噬性淋巴细胞组织细胞增生症(FHL)是一种遗传异质性高发性综合症,由无法控制且无效的T淋巴细胞,NK细胞和巨噬细胞浸润多个器官的增殖和活化引起。在此,提出患有肝炎和非典型脑损伤的患者。遗传研究显示STXP2基因发生纯合突变;因此,确认了FHL5的诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号